US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist

1.220
+0.130+11.93%

Close Nov 27 16:00 ET

1.220
0.0000.00%

Post 17:27 ET

77.29MMarket Cap-1340P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.268M	--
--	2024/Q4	-- / 1.701M	--
--	2024/Q3	3.336M / 1.520M	--
--	2024/Q2	2.658M / 1.289M	--
--	2024/Q1	1.717M / 1.213M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.268M--

--2024/Q4-- / 1.701M--

--2024/Q33.336M / 1.520M--

--2024/Q22.658M / 1.289M--

--2024/Q11.717M / 1.213M--

Unlock Free Earnings Estimates

Open Account

Cue Biopharma Earnings Reports

Cue Biopharma | 10-Q: Q3 2024 Earnings Report

Nov 14 16:08 ET

Cue Biopharma | 8-K: Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 14 16:07 ET

Cue Biopharma | 10-Q: Q2 2024 Earnings Report

Aug 14 16:07 ET

Cue Biopharma | 10-Q: Q1 2024 Earnings Report

May 9 16:05 ET

Analyst Rating

Updated: Nov 20, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall